Reactive oxygen species and reactive nitrogen species in epigenetic modifications

[1]  S. Jagannath,et al.  Phase I trial of vorinostat combined with bortezomib for the treatment of relapsing and/or refractory multiple myeloma. , 2012, Clinical lymphoma, myeloma & leukemia.

[2]  M. Esteller,et al.  DNA methylation profiling in the clinic: applications and challenges , 2012, Nature Reviews Genetics.

[3]  S. Chan,et al.  Synergistic effects of suberoylanilide hydroxamic acid combined with cisplatin causing cell cycle arrest independent apoptosis in platinum-resistant ovarian cancer cells. , 2012, International journal of oncology.

[4]  S. Matalon,et al.  Participation of miR-200 in pulmonary fibrosis. , 2012, The American journal of pathology.

[5]  Poshen B. Chen,et al.  Mbd3/NURD Complex Regulates Expression of 5-Hydroxymethylcytosine Marked Genes in Embryonic Stem Cells , 2011, Cell.

[6]  H. Stunnenberg,et al.  5-Hydroxymethylcytosine: a new kid on the epigenetic block? , 2011, Molecular systems biology.

[7]  Peter J. Barnes,et al.  Defect of Adaptation to Hypoxia in Patients With COPD Due to Reduction of Histone Deacetylase 7 , 2011, Chest.

[8]  O. Mariani,et al.  miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response , 2011, Nature Medicine.

[9]  C. Plass,et al.  Cancer chemoprevention by targeting the epigenome. , 2011, Current drug targets.

[10]  R. Hayes,et al.  Global Levels of Histone Modifications in Peripheral Blood Mononuclear Cells of Subjects with Exposure to Nickel , 2011, Environmental health perspectives.

[11]  M. Valko,et al.  Importance of iron chelation in free radical-induced oxidative stress and human disease. , 2011, Current pharmaceutical design.

[12]  S. Gray.  Epigenetic treatment of neurological disease. , 2011, Epigenomics.

[13]  Stephen Yau,et al.  The role of inflammation in the pathogenesis of lung cancer , 2011, Expert opinion on therapeutic targets.

[14]  J. Ryu,et al.  Effects and Mechanisms of the Combination of Suberoylanilide Hydroxamic Acid and Bortezomib on the Anticancer Property of Gemcitabine in Pancreatic Cancer , 2011, Pancreas.

[15]  W. Reik,et al.  DNA demethylases: a new epigenetic frontier in drug discovery. , 2011, Drug discovery today.

[16]  J. Qian,et al.  miR-29 is a major regulator of genes associated with pulmonary fibrosis. , 2011, American journal of respiratory cell and molecular biology.

[17]  S. Goto,et al.  Age-associated neurodegeneration and oxidative damage to lipids, proteins and DNA. , 2011, Molecular aspects of medicine.

[18]  A. Cyr,et al.  The redox basis of epigenetic modifications: from mechanisms to functional consequences. , 2011, Antioxidants & redox signaling.

[19]  I. Rahman,et al.  Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease. , 2011, Toxicology and applied pharmacology.

[20]  T. Carell,et al.  5-Hydroxymethylcytosine, the sixth base of the genome. , 2011, Angewandte Chemie.

[21]  F. Fuks,et al.  Regulation of mammalian DNA methyltransferases: a route to new mechanisms , 2011, EMBO reports.

[22]  Na-Yu Chia,et al.  Hypothesis: Environmental regulation of 5-hydroxymethylcytosine by oxidative stress , 2011, Epigenetics.

[23]  Lucia Anna Muscarella,et al.  Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer , 2011, Epigenetics.

[24]  P. Palozza,et al.  Lycopene Inhibits NF-kB-Mediated IL-8 Expression and Changes Redox and PPARγ Signalling in Cigarette Smoke–Stimulated Macrophages , 2011, PloS one.

[25]  Fang Liu,et al.  Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway. , 2011, Cellular signalling.

[26]  G. Goodall,et al.  Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[27]  P. Fasanaro,et al.  miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition , 2011, Cell Death and Differentiation.

[28]  G. Scapagnini,et al.  Modulation of Nrf2/ARE Pathway by Food Polyphenols: A Nutritional Neuroprotective Strategy for Cognitive and Neurodegenerative Disorders , 2011, Molecular Neurobiology.

[29]  L. Yarmus,et al.  Targeting Nrf2 Signaling Improves Bacterial Clearance by Alveolar Macrophages in Patients with COPD and in a Mouse Model , 2011, Science Translational Medicine.

[30]  L. Rasmussen,et al.  The Importance of Mitochondrial DNA in Aging and Cancer , 2011, Journal of aging research.

[31]  K. Tchou-Wong,et al.  Effects of Nickel Treatment on H3K4 Trimethylation and Gene Expression , 2011, PloS one.

[32]  S. Biswal,et al.  Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress , 2011, Biochemical and biophysical research communications.

[33]  N. Voelkel,et al.  Inhibition of histone deacetylase causes emphysema. , 2011, American journal of physiology. Lung cellular and molecular physiology.

[34]  Jia Li,et al.  Histone deacetylase inhibitor activity in royal jelly might facilitate caste switching in bees , 2011, EMBO reports.

[35]  K. O'Byrne,et al.  The Role of Epigenetics in Resistance to Cisplatin Chemotherapy in Lung Cancer , 2011, Cancers.

[36]  M. Valko,et al.  Arsenic: toxicity, oxidative stress and human disease , 2011, Journal of applied toxicology : JAT.

[37]  J. Riethoven,et al.  miR-27b*, an oxidative stress-responsive microRNA modulates nuclear factor-kB pathway in RAW 264.7 cells , 2011, Molecular and Cellular Biochemistry.

[38]  A. Jeltsch,et al.  Structure and Function of Mammalian DNA Methyltransferases , 2011, Chembiochem : a European journal of chemical biology.

[39]  J. Denu,et al.  Dynamic Interplay between Histone H3 Modifications and Protein Interpreters: Emerging Evidence for a “Histone Language” , 2011, Chembiochem : a European journal of chemical biology.

[40]  A. Goel,et al.  Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. , 2010, Biochemical pharmacology.

[41]  Ronghe Zhang,et al.  Hypoxia and nickel inhibit histone demethylase JMJD1A and repress Spry2 expression in human bronchial epithelial BEAS-2B cells. , 2010, Carcinogenesis.

[42]  Qiang Yu,et al.  The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML. , 2010, Blood.

[43]  K. O'Byrne,et al.  Targeting oxidative stress in cancer , 2010, Expert opinion on therapeutic targets.

[44]  M. Esteller,et al.  Epigenetic modifications and human disease , 2010, Nature Biotechnology.

[45]  T. Tollefsbol,et al.  Epigenetic targets of bioactive dietary components for cancer prevention and therapy , 2010, Clinical Epigenetics.

[46]  H. Allgayer,et al.  Loss of miR-200c Expression Induces an Aggressive, Invasive, and Chemoresistant Phenotype in Non–Small Cell Lung Cancer , 2010, Molecular Cancer Research.

[47]  Ju-Hee Lee,et al.  Inhibition of histone deacetylase 10 induces thioredoxin-interacting protein and causes accumulation of reactive oxygen species in SNU-620 human gastric cancer cells , 2010, Molecules and cells.

[48]  Vivian X. Fu,et al.  Superoxide dismutase 1 knockdown induces oxidative stress and DNA methylation loss in the prostate , 2010, Epigenetics.

[49]  P. Clemons,et al.  Distinct Biological Network Properties between the Targets of Natural Products and Disease Genes , 2010, Journal of the American Chemical Society.

[50]  I. Adcock,et al.  Treatment effects of low-dose theophylline combined with an inhaled corticosteroid in COPD. , 2010, Chest.

[51]  Steven Henikoff,et al.  Histone variants — ancient wrap artists of the epigenome , 2010, Nature Reviews Molecular Cell Biology.

[52]  Yi Zhang,et al.  Nickel Ions Inhibit Histone Demethylase JMJD1A and DNA Repair Enzyme ABH2 by Replacing the Ferrous Iron in the Catalytic Centers* , 2009, The Journal of Biological Chemistry.

[53]  P. Elliott,et al.  A protein deacetylase SIRT1 is a negative regulator of metalloproteinase‐9 , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  K. O'Byrne,et al.  Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy , 2009, Journal of cellular and molecular medicine.

[55]  M. Gaca,et al.  The role of oxidative stress in the biological responses of lung epithelial cells to cigarette smoke , 2009, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[56]  I. Adcock,et al.  Glucocorticoid resistance in inflammatory diseases , 2009, The Lancet.

[57]  Max Costa,et al.  Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium. , 2009, Metallomics : integrated biometal science.

[58]  Y. Murakumo,et al.  Characterization of the HDAC1 complex that regulates the sensitivity of cancer cells to oxidative stress. , 2009, Cancer research.

[59]  Hongwei Yao,et al.  Histone deacetylase 2 is phosphorylated, ubiquitinated, and degraded by cigarette smoke. , 2009, American journal of respiratory cell and molecular biology.

[60]  R. McManus,et al.  NF-κB regulation: the nuclear response , 2009, Journal of cellular and molecular medicine.

[61]  Donna D. Zhang,et al.  Acetylation of Nrf2 by p300/CBP Augments Promoter-Specific DNA Binding of Nrf2 during the Antioxidant Response , 2009, Molecular and Cellular Biology.

[62]  K. Igarashi,et al.  Bach1 Modulates Heme Oxygenase-1 Expression in the Neonatal Mouse Lung , 2009, Pediatric Research.

[63]  Ranjit K. Goudar,et al.  Hypoxia, angiogenesis, and lung cancer , 2008, Current oncology reports.

[64]  S. Goodman,et al.  RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy. , 2008, Cancer research.

[65]  Danny Reinberg,et al.  Is there a code embedded in proteins that is based on post-translational modifications? , 2008, Nature Reviews Molecular Cell Biology.

[66]  Rui Wang,et al.  Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues. , 2008, Biochemical and biophysical research communications.

[67]  I. Adcock,et al.  Molecular mechanisms of corticosteroid resistance. , 2008, Chest.

[68]  I. Rahman.  Dietary polyphenols mediated regulation of oxidative stress and chromatin remodeling in inflammation. , 2008, Nutrition reviews.

[69]  A. Burny,et al.  A pervasive role of histone acetyltransferases and deacetylases in an NF-kappaB-signaling code. , 2008, Trends in biochemical sciences.

[70]  B. Crestani,et al.  Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema , 2008, Thorax.

[71]  J. Qu,et al.  NF-kappaB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK. , 2008, Biochimica et biophysica acta.

[72]  P. Chakravarty,et al.  Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2. , 2008, American journal of respiratory cell and molecular biology.

[73]  I. Rahman,et al.  Sirt1, an Antiinflammatory and Antiaging Protein, Is Decreased in Lungs of Patients with Chronic Obstructive Pulmonary Disease at a Glance Commentary , 2022 .

[74]  I. Rahman,et al.  Deacetylases and NF-kappaB in redox regulation of cigarette smoke-induced lung inflammation: epigenetics in pathogenesis of COPD. , 2008, Antioxidants & redox signaling.

[75]  Y. Rojanasakul,et al.  Inflammation and Lung Cancer: Roles of Reactive Oxygen/Nitrogen Species , 2008, Journal of toxicology and environmental health. Part B, Critical reviews.

[76]  M. Sezer,et al.  High levels of oxidative stress in patients with advanced lung cancer , 2008, Respirology (Carlton South. Print).

[77]  Yi Zhang,et al.  New Nomenclature for Chromatin-Modifying Enzymes , 2007, Cell.

[78]  G. Semenza,et al.  Hypoxia-Inducible Factor 1 (HIF-1) Pathway , 2007, Science's STKE.

[79]  L. Sowers,et al.  Inflammation-mediated cytosine damage: a mechanistic link between inflammation and the epigenetic alterations in human cancers. , 2007, Cancer research.

[80]  L. Sowers,et al.  Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. , 2007, Cancer research.

[81]  I. Rahman,et al.  Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[82]  C. Glass,et al.  Expression of Nrf2 in Neurodegenerative Diseases , 2007, Journal of neuropathology and experimental neurology.

[83]  I. Rahman,et al.  Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells , 2006, Respiratory research.

[84]  J. Herman,et al.  Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer , 2006, PLoS medicine.

[85]  I. Adcock,et al.  Oxidative stress and redox regulation of lung inflammation in COPD , 2006, European Respiratory Journal.

[86]  D. Parkin,et al.  The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.

[87]  L. Howells,et al.  Involvement of Nrf2, p38, B-Raf, and Nuclear Factor-κB, but Not Phosphatidylinositol 3-Kinase, in Induction of Hemeoxygenase-1 by Dietary Polyphenols , 2006, Molecular Pharmacology.

[88]  R. Dashwood,et al.  Chemoprotection by sulforaphane: keep one eye beyond Keap1. , 2006, Cancer letters.

[89]  S. Reddy,et al.  Nrf2 defends the lung from oxidative stress. , 2006, Antioxidants & redox signaling.

[90]  Takahiro Shibata,et al.  Oxidative and Electrophilic Stresses Activate Nrf2 through Inhibition of Ubiquitination Activity of Keap1 , 2006, Molecular and Cellular Biology.

[91]  Xianglin Shi,et al.  Carcinogenic effect of nickel compounds , 2005, Molecular and Cellular Biochemistry.

[92]  I. Adcock,et al.  Decreased histone deacetylase activity in chronic obstructive pulmonary disease. , 2005, The New England journal of medicine.

[93]  Makoto Kobayashi,et al.  Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. , 2005, Antioxidants & redox signaling.

[94]  M. Brand,et al.  Heme regulates the dynamic exchange of Bach1 and NF-E2-related factors in the Maf transcription factor network. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[95]  Jiuhong Kang,et al.  Nickel-induced histone hypoacetylation: the role of reactive oxygen species. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[96]  Max Costa,et al.  Epigenetics and the Environment , 2003, Annals of the New York Academy of Sciences.

[97]  I. Rahman.  Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. , 2003, Journal of biochemistry and molecular biology.

[98]  I. Rahman.  Oxidative stress, transcription factors and chromatin remodelling in lung inflammation. , 2002, Biochemical pharmacology.

[99]  H. Scher,et al.  The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[100]  I. Adcock,et al.  A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[101]  W. MacNee,et al.  Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. , 2002, Molecular and cellular biochemistry.

[102]  W. E. Fahl,et al.  Functional characterization of transcription regulators that interact with the electrophile response element. , 2001, Biochemical and biophysical research communications.

[103]  T. Ekström,et al.  The human histone deacetylase family. , 2001, Experimental cell research.

[104]  I. Adcock,et al.  Glucocorticoid Receptor Recruitment of Histone Deacetylase 2 Inhibits Interleukin-1β-Induced Histone H4 Acetylation on Lysines 8 and 12 , 2000, Molecular and Cellular Biology.

[105]  J. Fahey,et al.  Chemoprotection against cancer by phase 2 enzyme induction. , 1995, Toxicology letters.

[106]  Min Gao,et al.  Altered oxidative stress responses in nickel-resistant mammalian cells. , 1994, Cancer research.

[107]  C. Rosen,et al.  NF-kappa B subunit-specific regulation of the interleukin-8 promoter , 1993, Molecular and cellular biology.

[108]  S. Biswal,et al.  Retraction: Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients. , 2014, The Journal of clinical investigation.

[109]  Shiyong Wu,et al.  MicroRNAs, cancer and cancer stem cells. , 2011, Cancer letters.

[110]  H. Kasai,et al.  DNA methylation by dimethyl sulfoxide and methionine sulfoxide triggered by hydroxyl radical and implications for epigenetic modifications. , 2010, Bioorganic & medicinal chemistry letters.

[111]  A. Mantovani,et al.  Cancer: Inflaming metastasis , 2008, Nature.

[112]  T. Kietzmann,et al.  Superoxide and derived reactive oxygen species in the regulation of hypoxia-inducible factors. , 2007, Methods in enzymology.

[113]  A. Bird,et al.  Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). , 2004, Nucleic acids research.

[114]  B. Halliwell,et al.  Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. , 1996, The Biochemical journal.